Biotech Values

[orangeone]

MNTA Does seem to have or should be able to obtain enox patents with claim language for production despite the cafc decision which concerns just the analysis patent. Just a minor matter of claim language potentially. The patents could be a convenient and legal pretext underlying a settlement. Ie if Amphastar could be kicked out of the market there could be enough incentive to get back to duopoly?